Founded in 1971 in the United States, a global dietary supplement giant and a well-known manufacturer of herbal and vitamin products in the United States, in 2016, Tomson By-Health established a joint venture with NBTY and obtained the permanent right to operate and use the trademark of Nature's Treasure in the Chinese market

NBTY WAS FOUNDED IN 1971 AS NATURE'S BOUNTY. INC), AND IN MAY 1990, IT WAS OFFICIALLY RENAMED NBTY.INC. It is headquartered in New York, USA. Today, NBTY has become a leading comprehensive company engaged in R&D, production and sales of high-quality nutritional supplements in the world. NBTY was listed on the NASDAQ in 1992 and transferred to the New York Stock Exchange in 2003.

Founded in 1971 and headquartered in New York, NBTY is a comprehensive company integrating R&D, production and sales of high-quality nutritional supplements, with a sales network in more than 120 countries around the world. In 2007, it entered the Chinese market and established Nuotianyuan (China) Trading Co., Ltd. to operate its Nature's Treasure brand and Merrix Sports Nutrition brand to meet the multi-faceted needs of people of different ages.

On March 11, 2016, By-Health established a joint venture with NBTY, the world's largest dietary supplement company, to obtain the permanent operation rights and trademark rights of Nature's Bounty and Met-RX in the Chinese market.

It is reported that in this joint venture, Tomson Beijian plans to inject 80 million to 120 million yuan, with a shareholding ratio of 60%; NBTY will inject the business of the existing Natures Bounty and Met-RX brands in the Chinese market, as well as the cross-border e-commerce business, into the joint venture, with a 40% stake. Tang Hui, the chairman of Tomson Beijian Pharmaceutical Co., Ltd., will serve as the chairman of the joint venture, the CEO and the main management team will be dispatched by Tomson Beijian, and NBTY will send the CFO and part of the team.